FABP2

Fatty acid-binding protein, intestinal · P12104 · FABP2 on Sugi Atlas →

58,821 patent compounds predicted against FABP2, 47,796 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
Bezafibrate Bezafibrate (SCHEMBL16299) 1.00 2/20
Fenofibric Acid Fenofibric Acid (SCHEMBL16377) 1.00 2/20
Clofibric Acid Clofibric Acid (SCHEMBL102826) 0.83 2/20
Fenofibrate Fenofibrate (SCHEMBL4670) 0.67 2/20
SCHEMBL135713 SCHEMBL135713 0.62 2/20
Clofibric Acid Clofibric Acid (SCHEMBL147972) 0.59 2/20
Ciprofibrate Ciprofibrate (SCHEMBL26870) 0.50 2/20
Beclobrate Beclobrate (SCHEMBL49779) 0.43 2/20
Meclofenamic Acid Meclofenamic Acid (SCHEMBL106) 1.00 1/20
Stearic Acid Stearic Acid (SCHEMBL659) 1.00 1/20
Flurbiprofen Flurbiprofen (SCHEMBL2248) 1.00 1/20
Decanoic Acid Decanoic Acid (SCHEMBL2682) 1.00 1/20
Octanoic Acid Octanoic Acid (SCHEMBL3933) 1.00 1/20
Dodecanoate Dodecanoate (SCHEMBL5895) 1.00 1/20
Heptadecanoic Acid Heptadecanoic Acid (SCHEMBL5941) 1.00 1/20
Palmitic Acid Palmitic Acid (SCHEMBL6177) 1.00 1/20
Pentadecanoic Acid Pentadecanoic Acid (SCHEMBL6311) 1.00 1/20
Myristic Acid Myristic Acid (SCHEMBL6374) 1.00 1/20
Arachidic Acid Arachidic Acid (SCHEMBL6539) 1.00 1/20
Behenic Acid Behenic Acid (SCHEMBL6579) 1.00 1/20

Clinical trials — most relevant to FABP2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effect of 8-week Supplementation With Black Chokeberry on Recovery in Highly Trained Rowers PHASE4COMPLETED
Effect of Pentoxifylline Versus Probiotic on Preterm Neonates With Necrotizing Enterocolitis PHASE3COMPLETED
Prediction of NEC With Urinary iFABP PHASE2WITHDRAWN
Intestinal Permeability PHASE2COMPLETED
Vagal Nerve Stimulation for Intestinal Barrier Dysfunction in Healthy Volunteers PHASE1COMPLETED
Plasma i-FABP as Predictor for Irreversible Bowel Ischemia nanUNKNOWN
Effects of Tomato Consumption on Steatosis, Intestinal Function and Glucose and Lipid Metabolism in Subjects With NAFLD nanCOMPLETED
Gut, Inflammation and Nutrition in Adult Patients After Fontan Operation nanCOMPLETED
Inflamation, Gut Leakage, Iron Status After 6000m Ergometer Test in Elite Rowers. nanCOMPLETED
Influence of a Mediterranean Diet Combined With a Physical Activity Intervention, on NAFLD and Inflammation Parameters. nanCOMPLETED
Modified Perfusion for Neonatal Aortic Arch Reconstruction nanCOMPLETED
The Detrimental Course of Acute Intestinal Ischemia nanUNKNOWN
The Effect of Probiotics on Systemic Inflammation and Metabolic Endotoxemia in Patients Undergoing Bariatric Surgery nanUNKNOWN
Placebo Controlled Study for Characterisation of Immunological Effects and Safety of Active O2 nanCOMPLETED
Searching Biomarkers of Acute Intestinal Ischemic Injuries nanRECRUITING
Enterocyte Injury and Acute Gastrointestinal Dysfunction in Critical Illness nanNOT_YET_RECRUITING
Gluten Free Oat (Cultivar Saul) in Celiac Disease in Remission nanCOMPLETED
Intestinal Fatty Acid-binding Protein (I-FABP) Levels in Pediatric Celiac Patients nanUNKNOWN
Persistent Multiorgan Failure in Intensive Care Units nanCOMPLETED
Postprandial Fatty Acids and FABP2 in Type 2 Diabetes Mellitus (DM) nanCOMPLETED
Effect of Intake in Bioactive Molecules From Natural or Pasteurised Milk on Gut Maturation in Very Premature Newborns nanCOMPLETED
Liver Steatosis in Pediatric CD Patients nanRECRUITING
Correlation Between Intra-abdominal Pressure, Biomarkers of Bacterial Translocation and Intestinal Wall Damage nanUNKNOWN
Endothelial Dysfunction and Nitric Oxyde During Laparoscopic Surgery nanCOMPLETED
Intestinal Fatty Acid Binding Protein in Very Low Birth Weight Infants With Meconium Obstruction nanCOMPLETED
Impact of RIVP on GI Function in Patients Undergoing Surgical Repair for ATAAD nanUNKNOWN
Predictive Factors for Anastomotic Leakage After Colorectal Surgery nanCOMPLETED
Fatty Acid Binding Proteins and Markers of Cellular Senescence in Cancer Survivors nanNOT_YET_RECRUITING
Effects of Ethanol on Gut Wall Integrity nanCOMPLETED
I-FABP as a Predictor of Gastrointestinal Involvement in Pediatric IgA Vasculitis nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a FABP2 binder may also engage these)

ProteinNameSimilarity
P55050 1.000 P55050 →
Q45KW7 1.000 Q45KW7 →
Q56JX9 1.000 Q56JX9 →
P02693 1.000 P02693 →
O02323 1.000 O02323 →
P51162 0.999 P51162 →
Q91775 0.997 Q91775 →
Q7M4G0 0.997 Q7M4G0 →
P83409 0.996 P83409 →
A6NFH5 0.996 A6NFH5 →
O02324 0.995 O02324 →
Q90239 0.995 Q90239 →
P41509 0.995 P41509 →
P0C241 0.994 P0C241 →
Q8MUC1 0.994 Q8MUC1 →
P0DM59 0.993 P0DM59 →
O01812 0.993 O01812 →
Q3T0Z2 0.993 Q3T0Z2 →
P81653 0.993 P81653 →
FABP6 Gastrotropin 0.993 landscape →
O01814 0.993 O01814 →
Q7M4G1 0.993 Q7M4G1 →
P50119 0.993 P50119 →
Q9DAK4 0.993 Q9DAK4 →
Q9I8L5 0.993 Q9I8L5 →
P41496 0.992 P41496 →
P80856 0.992 P80856 →
P81400 0.992 P81400 →
P29498 0.992 P29498 →
Q8JJ04 0.992 Q8JJ04 →